Daniel Tébar, Xavier Carrillo, Bruno García Del Blanco, Joan Antoni Gómez-Hospital, Luis Nombela, Eduardo Molina, Guillermo Galeote, Victoria Vilalta, Vicenc Serra-García, Guillem Muntané Carol, Santiago Jiménez-Valero, Eduard Fernandez-Nofrerias, Álvaro Calabuig-Goena, Alfonso Jurado-Román, Ángel Sánchez-Recalde, María Fernández Velasco, Lisardo Pérez-Solares, Raúl Moreno
BACKGROUND: Previous studies have documented a high rate of implantation success with the ACURATE neo2 valve, as well as a reduction in paravalvular leak (PVL) compared to its predecessor, the ACURATE neo. However, there are no studies that have reviewed and compared the long-term clinical and hemodynamic outcomes of these patients. AIMS: This study aimed to evaluate the results of the ACURATE neo transcatheter aortic valve in a real-world context, and to compare the results of the outcomes of both generations of this device (ACURATE neo and ACURATE neo2), with a specific focus on procedural success, safety, and long-term effectiveness...
April 5, 2024: Catheterization and Cardiovascular Interventions